Vincent Gaynor remembers, almost to the minute, when he realized his part in birthing the breakthrough gene therapy Zolgensma ...

Just a few weeks France's Sanofi made a $40 million investment in Gyroscope for first refusal rights on the gene therapy – called GT005 – but it is Novartis that has swooped on the company and ...

Cell and gene therapy is the hottest area in biotech at the moment, and Gilead’s $11.9bn acquisition of Kite Pharma in October has been followed by Celgene’s $9bn buyout of Juno Therapeutics.

The Medical University of South Carolina Health has established the Rena N. Grant Sickle Cell Center to help treat those ...

The Bermuda National Trust [BNT] held its Plant & Bake Sale this weekend, offering a diverse selection of plants, baked goods, and local produce at Waterville on Pomander Road in Paget.

The high-dose Spinraza is Biogen's answer to competitors such as Novartis' gene therapy Zolgensma. Specifically, the combo is approved in Europe for patients with epidermal growth factor receptor ...

Feb. 20, 2025 — Biologists have discovered a new type of RNA-splicing regulation that helps to determine which protein-coding exons will be included in messenger RNA ...

DiveWire guarantees visibility for your news announcements through instant distribution to BioPharma Dive’s audience and its 176,000 newsletter subscribers for 21 days.